Abstract:Abstract Background Contrast-enhanced ultrasound (CEUS) could provide a lot of information of renal blood flow. Renal blood flow is an excellent marker of inflammatory and fibrotic processes in the kidney such as glomerulonephritis. Therefore, in patients with these diseases, renal CEUS can be both a prognostic marker and an index of response to therapy. Currently in the literature there are preliminary studies showing the role of CEUS in terms of histology and outcome in the evaluation of patients with glomerulonephritis. In this pilot study we used perfusion CEUS parameters (WiR and WoR; WiAUC and WoAUC) as possible markers of renal microvascular damage. We compared the perfusion parameters with the clinical and histological findings of our patients. Method Eighteen patients with clinical and laboratory signs of glomerulonephritis were enrolled. All patients underwent ultrasound-assisted renal biopsy and B-mode ultrasound examination, color Doppler ultrasound and contrast-enhanced ultrasound. Time Intensity (TI) curves were obtained from renal CEUS. TI curves and several quantitative perfusion parameters were defined using VueBox® Quantitation Software. Results From April to October 2022, 18 patients (12 men and 6 women) with clinical and laboratory suspicion of glomerular disease were enrolled. Median age was 48.05 years, all patients underwent renal biopsy and contrast-enhanced ultrasound at basal condition. Table 1 shows patients characteristics. CKD patients were stratified into two groups according to their eGFR: group I (eGFR < 60 ml/min/1.73 m2, n. = 4) and group II (eGFR ≥ 60 ml/min/1.73 m2, n. = 3). Moreover, we divided patients into two groups based on the presence of nephrotic-range proteinuria (≥ 3.5 g/24h). At this time, seven patient data are suitable for analysis. The small sample size at present does not allow for statistical significance. However, in our study, the persistence of contrast agent signal during the wash-out phase was differed markedly in correlation with the degree of CKD. In particular, we observed a slower wash-in phase in the presence of vascular hyalinosis (Fig. 1). Conclusion Our experience seems to confirm that CEUS parameters can be excellent indicators both in terms of patient disease outcomes and histological data. CEUS can effectively and quantitatively demonstrate renal microvascular perfusion in patients with glomerulonephritis. Future goal is that CEUS could also be a prognostic and follow-up marker after renal biopsy in patients with glomerulonephritis.

#6323 RENAL CONTRAST-ENHANCED ULTRASOUND AND GLOMERULONEPHRITIS: A GOOD MARKER OF DISEASE ACTIVITY

Use of Contrast-Enhanced Ultrasound to Study Relationship between Serum Uric Acid and Renal Microvascular Perfusion in Diabetic Kidney Disease

[Contrast-Enhanced Ultrasound Parameters for Early Chronic Kidney Diseases and Their Associations with Laboratory Results].

The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology

Evaluation of Contrast-Enhanced Ultrasound in Diagnosis of Acute Kidney Injury of Patients in Intensive Care Unit

Association of Contrast-Enhanced Ultrasound-Derived Kidney Cortical Microvascular Perfusion with Kidney Function

A pilot trial to evaluate the clinical usefulness of contrast-enhanced ultrasound in predicting renal outcomes in patients with acute kidney injury

[Value of Real-Time Contrast-Enhanced Ultrasound in Diagnosis of Renal Solid Renal Lesions].

Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report

Contrast-Enhanced Ultrasound for Assessing Renal Perfusion Impairment and Predicting Acute Kidney Injury to Chronic Kidney Disease Progression.

Assessment of Renal Perfusion with Contrast-Enhanced Ultrasound: Preliminary Results in Early Diabetic Nephropathies

0667: Chronic Renal Dysfunction: Quantitative Diagnosis with Contrast-Enhanced Ultrasonography – Initial Experience

Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging

Contrast-Enhanced Ultrasound Assessment of Renal Parenchymal Perfusion in Patients with Atherosclerotic Renal Artery Stenosis to Predict Renal Function Improvement after Revascularization.

Feasibility of contrast-enhanced ultrasonography (CEUS) in evaluating renal microvascular perfusion in pediatric patients

Quantitative evaluation of contrast-enhanced ultrasound in early diagnosis of renal dysfunction

Contrast-enhanced ultrasound with SonoVue could accurately assess the renal microvascular perfusion in diabetic kidney damage.

Comparative Study of Contrast-Enhanced Ultrasonography and 99mTc-DTPA Renography in the Diagnosis of Kidney Dysfunction

Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation—Results from a Prospective Single-Center Study

Benefit of contrast enhanced ultrasound for detection of ischaemic lesions and arterio venous fistulas in renal transplants - a feasibility study

Evaluation of Renal Microperfusion in Diabetic Patients with Kidney Injury by Contrast‐Enhanced Ultrasound